uric acid has been researched along with Dementia, Vascular in 13 studies
Uric Acid: An oxidation product, via XANTHINE OXIDASE, of oxypurines such as XANTHINE and HYPOXANTHINE. It is the final oxidation product of purine catabolism in humans and primates, whereas in most other mammals URATE OXIDASE further oxidizes it to ALLANTOIN.
uric acid : An oxopurine that is the final oxidation product of purine metabolism.
6-hydroxy-1H-purine-2,8(7H,9H)-dione : A tautomer of uric acid having oxo groups at C-2 and C-8 and a hydroxy group at C-6.
7,9-dihydro-1H-purine-2,6,8(3H)-trione : An oxopurine in which the purine ring is substituted by oxo groups at positions 2, 6, and 8.
Dementia, Vascular: An imprecise term referring to dementia associated with CEREBROVASCULAR DISORDERS, including CEREBRAL INFARCTION (single or multiple), and conditions associated with chronic BRAIN ISCHEMIA. Diffuse, cortical, and subcortical subtypes have been described. (From Gerontol Geriatr 1998 Feb;31(1):36-44)
| Excerpt | Relevance | Reference |
|---|---|---|
| "To explore the association between uric acid (UA) levels and vascular dementia (VaD) and Parkinson's disease dementia (PDD), a meta-analysis was conducted." | 9.41 | Uric acid levels and their association with vascular dementia and Parkinson's disease dementia: a meta-analysis. ( Cen, K; Cui, Y; Feng, X; Hou, X; Li, Q, 2023) |
| "To explore the association between uric acid (UA) levels and vascular dementia (VaD) and Parkinson's disease dementia (PDD), a meta-analysis was conducted." | 5.41 | Uric acid levels and their association with vascular dementia and Parkinson's disease dementia: a meta-analysis. ( Cen, K; Cui, Y; Feng, X; Hou, X; Li, Q, 2023) |
| " The single ascending dose of Naoqingzhiming tablet (180-2160 mg) were well tolerated in all enrolled subjects, without serious adverse events and adverse events leading to withdrawal from the study." | 3.11 | Safety, tolerability and pharmacokinetics of a Class I natural medicine with therapeutic potential for vascular dementia: Naoqingzhiming tablet. ( Cao, Y; Chen, M; Han, Y; Jiang, H; Jiang, X; Li, T; Lin, P; Liu, X; Sun, F; Tao, Y; Yan, F, 2022) |
| "It is known that hyperuricemia is recognized as an independent cardiovascular risk factor." | 2.82 | [The role of hyperuricemia in the development of cognitive changes in the elderly.] ( Ariev, AL; Kunitskaya, NA, 2022) |
| "Hyperuricemia has been recognized as an independent cardiovascular risk factor in epidemiological studies." | 2.58 | Uric Acid and Cognitive Function in Older Individuals. ( Meschi, T; Nouvenne, A; Prati, B; Tana, C; Ticinesi, A, 2018) |
| "Uric acid (UA) is an endogenous antioxidant, low levels of which are also implicated in neurodegenerative disease." | 1.91 | The Influence of Agricultural Work and Plasma Uric Acid on Hospital Admission for Alzheimer's Disease. ( Liu, H; Reynolds, GP; Wei, X, 2023) |
| "Uric acid (UA) is a major contributor to naturally-occurring antioxidant activity and is thought to have protective effects against neurodegenerative processes." | 1.56 | Uric Acid and High-Density Lipoprotein Cholesterol Are Differently Associated with Alzheimer's Disease and Vascular Dementia. ( Liu, H; Reynolds, GP; Wei, X, 2020) |
| "Uric acid (UA) has long been implicated as a critical cause of cardiovascular disease." | 1.46 | Uric acid is associated with vascular dementia in Chinese population. ( Cui, R; Liu, Y; Lu, K; Wang, Q; Xu, Y; Zhao, Y, 2017) |
| "the bilirubin level was obviously lower while the ua level was significantly higher in the Sivd group when compared with the controls." | 1.40 | Serum antioxidant levels associated with subcortical ischemic vascular disease. ( Hao, J; Liu, H; Sun, Z; Wang, L; Zhang, C; Zhou, X; Zhu, M; Zhu, X, 2014) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (7.69) | 18.2507 |
| 2000's | 1 (7.69) | 29.6817 |
| 2010's | 5 (38.46) | 24.3611 |
| 2020's | 6 (46.15) | 2.80 |
| Authors | Studies |
|---|---|
| Lin, P | 1 |
| Tao, Y | 1 |
| Sun, F | 1 |
| Jiang, X | 1 |
| Li, T | 1 |
| Liu, X | 1 |
| Chen, M | 1 |
| Jiang, H | 1 |
| Yan, F | 1 |
| Han, Y | 1 |
| Cao, Y | 1 |
| Kunitskaya, NA | 1 |
| Ariev, AL | 1 |
| Li, Q | 1 |
| Cen, K | 1 |
| Cui, Y | 1 |
| Feng, X | 1 |
| Hou, X | 1 |
| Liu, H | 3 |
| Reynolds, GP | 2 |
| Wei, X | 2 |
| Serdarevic, N | 1 |
| Stanciu, AE | 1 |
| Begic, L | 1 |
| Uncanin, S | 1 |
| Tana, C | 1 |
| Ticinesi, A | 1 |
| Prati, B | 1 |
| Nouvenne, A | 1 |
| Meschi, T | 1 |
| Scheepers, LEJM | 1 |
| Jacobsson, LTH | 1 |
| Kern, S | 1 |
| Johansson, L | 1 |
| Dehlin, M | 1 |
| Skoog, I | 1 |
| Cervellati, C | 1 |
| Romani, A | 1 |
| Seripa, D | 1 |
| Cremonini, E | 1 |
| Bosi, C | 1 |
| Magon, S | 1 |
| Passaro, A | 1 |
| Bergamini, CM | 1 |
| Pilotto, A | 1 |
| Zuliani, G | 1 |
| Zhou, X | 1 |
| Wang, L | 1 |
| Zhang, C | 1 |
| Zhu, M | 1 |
| Zhu, X | 1 |
| Hao, J | 1 |
| Sun, Z | 1 |
| Xu, Y | 1 |
| Wang, Q | 1 |
| Cui, R | 1 |
| Lu, K | 1 |
| Liu, Y | 1 |
| Zhao, Y | 1 |
| Gackowski, D | 1 |
| Rozalski, R | 1 |
| Siomek, A | 1 |
| Dziaman, T | 1 |
| Nicpon, K | 1 |
| Klimarczyk, M | 1 |
| Araszkiewicz, A | 1 |
| Olinski, R | 1 |
| Tohgi, H | 1 |
| Abe, T | 1 |
| Takahashi, S | 1 |
| Kikuchi, T | 1 |
3 reviews available for uric acid and Dementia, Vascular
| Article | Year |
|---|---|
[The role of hyperuricemia in the development of cognitive changes in the elderly.]
Topics: Aged; Alzheimer Disease; Cognition; Cognitive Dysfunction; Dementia; Dementia, Vascular; Humans; Hyp | 2022 |
Uric acid levels and their association with vascular dementia and Parkinson's disease dementia: a meta-analysis.
Topics: Alzheimer Disease; Dementia; Dementia, Vascular; Humans; Parkinson Disease; Reproducibility of Resul | 2023 |
Uric Acid and Cognitive Function in Older Individuals.
Topics: Aged; Alzheimer Disease; Cognition; Cognitive Dysfunction; Dementia; Dementia, Vascular; Disease Pro | 2018 |
1 trial available for uric acid and Dementia, Vascular
| Article | Year |
|---|---|
Safety, tolerability and pharmacokinetics of a Class I natural medicine with therapeutic potential for vascular dementia: Naoqingzhiming tablet.
Topics: Area Under Curve; Dementia, Vascular; Dose-Response Relationship, Drug; Double-Blind Method; Healthy | 2022 |
9 other studies available for uric acid and Dementia, Vascular
| Article | Year |
|---|---|
The Influence of Agricultural Work and Plasma Uric Acid on Hospital Admission for Alzheimer's Disease.
Topics: Alzheimer Disease; Dementia, Vascular; Hospitals; Humans; Neurodegenerative Diseases; Pesticides; Ur | 2023 |
Uric Acid and High-Density Lipoprotein Cholesterol Are Differently Associated with Alzheimer's Disease and Vascular Dementia.
Topics: Aged; Alzheimer Disease; Biomarkers; Brain; Cholesterol, HDL; Dementia, Vascular; Female; Humans; Ma | 2020 |
Serum Uric Acid Concentration in Patients with Cerebrovascular Disease (Ischemic Stroke and Vascular Dementia).
Topics: Aged; Aged, 80 and over; Case-Control Studies; Cerebrovascular Disorders; Dementia, Vascular; Humans | 2020 |
Urate and risk of Alzheimer's disease and vascular dementia: A population-based study.
Topics: Adult; Alzheimer Disease; Dementia, Vascular; Female; Humans; Longitudinal Studies; Middle Aged; Ris | 2019 |
Oxidative balance, homocysteine, and uric acid levels in older patients with Late Onset Alzheimer's Disease or Vascular Dementia.
Topics: Advanced Oxidation Protein Products; Aged; Aged, 80 and over; Alzheimer Disease; Antioxidants; Cogni | 2014 |
Serum antioxidant levels associated with subcortical ischemic vascular disease.
Topics: Aged; Antioxidants; Bilirubin; Biomarkers; Brain Ischemia; Cross-Sectional Studies; Dementia, Vascul | 2014 |
Uric acid is associated with vascular dementia in Chinese population.
Topics: Aged; China; Cognitive Dysfunction; Dementia, Vascular; Female; Humans; Male; Middle Aged; Protectiv | 2017 |
Oxidative stress and oxidative DNA damage is characteristic for mixed Alzheimer disease/vascular dementia.
Topics: 8-Hydroxy-2'-Deoxyguanosine; Aged; Aged, 80 and over; Alzheimer Disease; Antioxidants; Ascorbic Acid | 2008 |
The urate and xanthine concentrations in the cerebrospinal fluid in patients with vascular dementia of the Binswanger type, Alzheimer type dementia, and Parkinson's disease.
Topics: Aged; Alzheimer Disease; Dementia, Multi-Infarct; Dementia, Vascular; Humans; Parkinson Disease; Psy | 1993 |